These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 26148143

  • 1. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
    Enevoldsen LH, Heaf J, Højgaard L, Zerahn B, Hasbak P.
    Clin Physiol Funct Imaging; 2017 Mar; 37(2):131-136. PubMed ID: 26148143
    [Abstract] [Full Text] [Related]

  • 2. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
    Ergün EL, Kiratli PO, Günay EC, Erbaş B.
    Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
    [Abstract] [Full Text] [Related]

  • 3. Lung, gastric, and soft tissue uptake of Tc-99m MDP and Ga-67 citrate associated with hypercalcemia.
    Castaigne C, Martin P, Blocklet D.
    Clin Nucl Med; 2003 Jun; 28(6):467-71. PubMed ID: 12911094
    [Abstract] [Full Text] [Related]

  • 4. Myocardial and vascular uptake of a bone tracer associated with secondary hyperparathyroidism.
    Kida T, Hujita Y, Sasaki M, Inoue J.
    Eur J Nucl Med; 1986 Jun; 12(3):151-4. PubMed ID: 3758104
    [Abstract] [Full Text] [Related]

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patients.
    Locatelli F, Dimkovic N, Spasovski G.
    Expert Opin Pharmacother; 2014 Jul; 15(10):1475-88. PubMed ID: 24914480
    [Abstract] [Full Text] [Related]

  • 7. [Value of bone scintigraphy in secondary (intestinal) hyperparathyroidism].
    Braun W, Heidenreich P, Guth H.
    Rofo; 1984 Apr; 140(4):457-63. PubMed ID: 6232181
    [Abstract] [Full Text] [Related]

  • 8. High renal activity on bone scintigrams. A sign of hypercalcaemia?
    Buxton-Thomas MS, Wraight EP.
    Br J Radiol; 1983 Dec; 56(672):911-4. PubMed ID: 6228281
    [Abstract] [Full Text] [Related]

  • 9. Secondary hyperparathyroidism among Nigerians with chronic kidney disease.
    Gimba ZM, Abene EE, Agbaji OOO, Agaba EI.
    Afr Health Sci; 2018 Jun; 18(2):446-457. PubMed ID: 30602972
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Age- and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning.
    Brenner W, Sieweke N, Bohuslavizki KH, Kampen WU, Zuhayra M, Clausen M, Henze E.
    Nuklearmedizin; 2000 Aug; 39(5):127-32. PubMed ID: 10984888
    [Abstract] [Full Text] [Related]

  • 13. A finding of myocardial uptake at a bone scintigraphy with Tc-99m HDP.
    Travascio L, Ciancamerla M, Colandrea M, Di Nicola AD, Giacomobono S, Ugolini F, Montesano T, Ronga G.
    Clin Ter; 2008 Aug; 159(6):419-20. PubMed ID: 19169601
    [Abstract] [Full Text] [Related]

  • 14. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
    Moore AE, Blake GM, Fogelman I.
    J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover?
    Blake GM, Siddique M, Frost ML, Moore AE, Fogelman I.
    Bone; 2011 Sep; 49(3):537-42. PubMed ID: 21689803
    [Abstract] [Full Text] [Related]

  • 17. Localization of a bone imaging agent in a calcified hematoma.
    Shih WJ, Han JK, Brandenburge S, Magoun S, Mostowycz L.
    J Nucl Med Technol; 1999 Mar; 27(1):45-7. PubMed ID: 10322576
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High prevalence of secondary hyperparathyroidism in chronic kidney disease patients on dialysis in Argentina.
    Douthat WG, Castellano M, Berenguer L, Guzmán MA, de Arteaga J, Chiurchiu CR, Massari PU, Garay G, Capra R, de La Fuente JL.
    Nefrologia; 2013 Mar; 33(5):657-66. PubMed ID: 24089157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.